Subclinical decrease in cardiac autonomic and diastolic function in patients with metabolic disorders: HSCAA study.
Subclinical decrease in cardiac autonomic and diastolic function in patients with metabolic disorders: HSCAA study.
复制标题
DOI：
10.1016/j.metop.2020.100025
复制
发表时间：
2020-03-01
期刊：
影响因子：
--
通讯作者：
Koyama, Hidenori
中科院分区：
文献类型：
--
作者：
Morimoto, Akiko;Kadoya, Manabu;Koyama, Hidenori
舒张功能下降导致的心力衰竭 (HFpEF) 是一个日益严重的健康问题，且患病率不断上升。我们检查了 605 名患有心力衰竭前期代谢性疾病的患者的亚临床心脏自主神经和舒张功能。葡萄糖不耐症或糖尿病或内脏肥胖的存在与心脏自主神经和舒张功能下降显着相关。较高的自主神经功能与较好的心脏舒张功能 (E/A) 参数显着相关（SDNN：r=0.306，p
Heart failure due to decreased diastolic function, HFpEF, is a growing health concern with rising prevalence. We examined subclinical cardiac autonomic and diastolic functions in 605 patients with metabolic diseases classified as pre-heart failure. Presence of glucose intolerance or diabetes, or visceral adiposity was significantly associated with reduced cardiac autonomic and diastolic functions. Higher autonomic functions were significantly associated with a parameter of better cardiac diastolic function (E/A) (SDNN: r=0.306, p